Key result
Dual aortic and mitral valve-in-valve implantation under VA-ECMO yields durable 3-year function in a single case.
Why the study?
Cardiogenic shock due to simultaneous degeneration of multiple prosthetic valves is rare and associated with prohibitive surgical risk.
Case Report (n=1)
Dual transcatheter valve-in-valve implantation (aortic and mitral) is feasible and can provide durable long-term recovery for patients in cardiogenic shock on VA-ECMO with prohibitive surgical risk.
BACKGROUND: Cardiogenic shock due to simultaneous degeneration of multiple prosthetic valves is rare and is associated with prohibitive surgical risk. CASE SUMMARY: A 73-year-old woman with 3 prior sternotomies presented with acute decompensated heart failure, which rapidly progressed to cardiogenic shock after atrial fibrillation. Multimodality imaging demonstrated severe dysfunction of both aortic and mitral bioprostheses, with biventricular dysfunction. Refractory shock necessitated venoarterial extracorporeal membrane oxygenation (ECMO). Given extreme surgical risk, a transcatheter strategy was pursued. Sequential transfemoral aortic and transseptal mitral valve-in-valve implantations were successfully performed under ECMO support. Hemodynamics improved immediately, allowing ECMO explantation. At the 3-year follow-up, both valves demonstrated durable function with sustained clinical recovery. DISCUSSION: The increasing integration of mechanical circulatory support with rapidly evolving transcatheter valve technologies is enabling a new paradigm of complex and high-risk structural heart interventions. TAKE-HOME MESSAGE: Dual transcatheter valve-in-valve implantation is feasible and effective in selected patients on mechanical circulatory support.
No takes yet. Share an insight, caveat, or question.
Palaparti et al. (2026) conducted a case report in Cardiogenic shock and severe dysfunction of aortic and mitral bioprostheses (n=1). Sequential transfemoral aortic and transseptal mitral valve-in-valve implantations under VA-ECMO support was evaluated on Valve function and clinical recovery. Dual transcatheter aortic and mitral valve-in-valve implantation under VA-ECMO support in a 73-year-old woman resulted in immediate hemodynamic improvement and durable function at 3 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: